Arrowhead Research | ARWR - 貿易債務者





貿易債務者 変化する 日付
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Incyte USD 1.05B 27.09M 2026-03
Ionis Pharmaceuticals USD 74M 8M 2026-03
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
Merck USD 11.78B 345M 2025-12
Moderna USD 71M 113M 2026-03
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Novartis USD 9.6B 2.69B 2026-03
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
TG Therapeutics USD 265.38M 33.86M 2025-09
Ultragenyx Pharmaceutical USD 158M 45.46M 2025-12
Vertex Pharmaceuticals USD 2B 56.7M 2026-03
Xencor USD 29.3M 7.49M 2025-12